Insights

Market Expansion Potential Dermavant Sciences, with a focus on innovative prescription therapies for dermatologic diseases, has a promising pipeline that can cater to the growing demand in the dermatology market, presenting significant sales opportunities for expansion.

Competitive Advantage By acquiring compounds that target unmet therapeutic needs, Dermavant Sciences has positioned itself uniquely among competitors, offering differentiated solutions that can be leveraged by sales teams to showcase the company's competitive advantage.

Financial Stability With a revenue range of $50M - 100M and recent funding of $160M, Dermavant Sciences demonstrates financial strength and stability, reassuring potential clients and partners of the company's capacity for long-term collaborations and investments.

Technology Integration Utilizing a tech stack that includes Power BI, Google Cloud, and more, Dermavant Sciences showcases a commitment to leveraging advanced technologies in its operations, offering a modern and efficient approach that can be appealing to tech-savvy clients.

Employee Engagement Impact With 201-500 employees and a dedication to improving patients' lives, Dermavant Sciences fosters a culture of purpose-driven work, which can resonate positively with clients seeking to partner with a company that prioritizes meaningful contributions to healthcare.

Dermavant Sciences, an Organon company Tech Stack

Dermavant Sciences, an Organon company uses 8 technology products and services including Power BI, cdnjs, Google Cloud, and more. Explore Dermavant Sciences, an Organon company's tech stack below.

  • Power BI
    Business Intelligence
  • cdnjs
    Content Delivery Network
  • Google Cloud
    Infrastructure As A Service
  • RSS
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Glassdoor
    Online Review Management
  • Zoom
    Web Conferencing
  • IIS
    Web Servers

Media & News

Dermavant Sciences, an Organon company's Email Address Formats

Dermavant Sciences, an Organon company uses at least 1 format(s):
Dermavant Sciences, an Organon company Email FormatsExamplePercentage
First.Last@dermavant.comJohn.Doe@dermavant.com
94%
First@dermavant.comJohn@dermavant.com
4%
FLast@dermavant.comJDoe@dermavant.com
1%
Last@dermavant.comDoe@dermavant.com
1%

Frequently Asked Questions

Where is Dermavant Sciences, an Organon company's headquarters located?

Minus sign iconPlus sign icon
Dermavant Sciences, an Organon company's main headquarters is located at 3780 Kilroy Airport Way Suite 250 Long Beach, CA 90806 US. The company has employees across 2 continents, including North AmericaEurope.

What is Dermavant Sciences, an Organon company's official website and social media links?

Minus sign iconPlus sign icon
Dermavant Sciences, an Organon company's official website is dermavant.com and has social profiles on LinkedIn.

How much revenue does Dermavant Sciences, an Organon company generate?

Minus sign iconPlus sign icon
As of November 2024, Dermavant Sciences, an Organon company's annual revenue reached $75M.

What is Dermavant Sciences, an Organon company's SIC code NAICS code?

Minus sign iconPlus sign icon
Dermavant Sciences, an Organon company's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dermavant Sciences, an Organon company have currently?

Minus sign iconPlus sign icon
As of November 2024, Dermavant Sciences, an Organon company has approximately 286 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: T. Z.Chief Medical Officer: P. B.Chief Financial Officer: M. S.. Explore Dermavant Sciences, an Organon company's employee directory with LeadIQ.

What industry does Dermavant Sciences, an Organon company belong to?

Minus sign iconPlus sign icon
Dermavant Sciences, an Organon company operates in the Biotechnology Research industry.

What technology does Dermavant Sciences, an Organon company use?

Minus sign iconPlus sign icon
Dermavant Sciences, an Organon company's tech stack includes Power BIcdnjsGoogle CloudRSSMicrosoftGlassdoorZoomIIS.

What is Dermavant Sciences, an Organon company's email format?

Minus sign iconPlus sign icon
Dermavant Sciences, an Organon company's email format typically follows the pattern of . Find more Dermavant Sciences, an Organon company email formats with LeadIQ.

How much funding has Dermavant Sciences, an Organon company raised to date?

Minus sign iconPlus sign icon
As of November 2024, Dermavant Sciences, an Organon company has raised $160M in funding. The last funding round occurred on Jun 07, 2021 for $160M.

When was Dermavant Sciences, an Organon company founded?

Minus sign iconPlus sign icon
Dermavant Sciences, an Organon company was founded in 2016.
Dermavant Sciences, an Organon company

Dermavant Sciences, an Organon company

Biotechnology ResearchCalifornia, United States201-500 Employees

A Passion for Science and a Commitment to Dermatology
Dermavant Sciences is a specialty biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. We are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-in-class therapies that improve patients’ lives. The patient is at the heart of everything we do.

Section iconCompany Overview

Headquarters
3780 Kilroy Airport Way Suite 250 Long Beach, CA 90806 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $160M

    Dermavant Sciences, an Organon company has raised a total of $160M of funding over 1 rounds. Their latest funding round was raised on Jun 07, 2021 in the amount of $160M.

  • $50M$100M

    Dermavant Sciences, an Organon company's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $160M

    Dermavant Sciences, an Organon company has raised a total of $160M of funding over 1 rounds. Their latest funding round was raised on Jun 07, 2021 in the amount of $160M.

  • $50M$100M

    Dermavant Sciences, an Organon company's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.